Arturo Molina

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Protagonist Therapeutics, Inc (PTGX)
Proxy statement

Current
Start not stated–present
Sutro Biopharma, Inc. (STRO)
Proxy statement

Start not stated–2022-11-04

Recorded roles and call appearances connecting this person to public companies.

PTGX

Current role

STRO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Protagonist Therapeutics, Inc (PTGX)	M.D., M.S., F.A.C.P. Chief Medical Officer	$572,000	—	$1,601,610	$1,543,628	$366,080	$11,912	$4,095,230
2024	Protagonist Therapeutics, Inc (PTGX)	M.D., M.S., F.A.C.P. Chief Medical Officer	$550,000	$66,000	$614,775	$1,892,514	$330,000	$10,912	$3,464,201
2019	Sutro Biopharma, Inc. (STRO)	M.D., M.S., FACP Chief Medical Officer	$453,500	—	—	$330,600	$163,260	—	$947,360
2018	Sutro Biopharma, Inc. (STRO)	M.D., M.S., FACP Chief Medical Officer	$440,300	—	$387,390	$2,306,240	$220,150	—	$3,354,080

No call appearances or filed executive changes recorded yet.